Acute kidney injury (AKI) is a potential complication of cardiac surgery. In animal models,
excess exogenous Cl- ion in the bloodstream is associated with AKI. Normal saline IV fluid
has higher levels of Cl- ion than the blood usually carries. An alternative IV fluid sold
under the name Isolyte has lower Cl- ion levels. There is no literature comparing AKI
outcomes in cardiac patients between patients receiving normal saline vs. Isolyte. The
investigators propose to recruit and randomize 30 trial-completing cardiac surgery patients
(up to 40 enrolled) into 2 study arms and compare renal outcomes.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
